Chemical composition and anti-inflammatory activities of essential oil from Trachydium roylei  by Wang, Yu-Tao et al.
ww.sciencedirect.com
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 6 0 2e6 0 9Available online at wScienceDirect
journal homepage: www.j fda-onl ine.comOriginal ArticleChemical composition and anti-inflammatory
activities of essential oil from Trachydium royleiYu-Tao Wang a,b, Liang Zhu c, Di Zeng c, Wei Long c, Si-Ming Zhu a,c,*
a College of Life and Geographic Sciences, Kashgar University, Kashgar, PR China
b The Key Laboratory of Ecology and Biological Resources in Yarkand Oasis at Colleges and Universities Under the
Department of Education of Xinjiang Uygur Autonomous Region, Kashgar University, Kashgar, PR China
c School of Food Science and Engineering, South China University of Technology, Guangzhou, PR Chinaa r t i c l e i n f o
Article history:
Received 18 October 2015
Received in revised form
2 February 2016
Accepted 15 February 2016
Available online 11 April 2016
Keywords:
anti-inflammatory activity
chemical composition
essential oil
Trachydium roylei* Corresponding author. School of Food Scie
District, Guangzhou 510640, PR China.
E-mail address: lfsmzhu@scut.edu.cn (S.-
http://dx.doi.org/10.1016/j.jfda.2016.02.009
1021-9498/Copyright © 2016, Food and Drug Ad
CC BY-NC-ND license (http://creativecommonsa b s t r a c t
Chemical composition, anti-inflammatory activity, and cytotoxicity of essential oils ob-
tained from the aerial parts of Trachydium roylei were investigated in this study. The
chemical composition of T. roylei essential oil was analyzed using gas chromatography
mass spectrometry. Fifty-nine components, representing 98.87% of the oils, were charac-
terized. The oils were predominated by aromatic compounds and monoterpene hydro-
carbons, and the main components were myristicin (25.35%), b-phellandrene (22.95%),
elemicine (7.69%), isoelemicin (5.48%), and cedrol (5.26%). The anti-inflammatory activity of
the oil in lipopolysaccharide-stimulated murine RAW 264.7 cells was evaluated. The oils
downregulated the production of proinflammatory cytokines, including tumor necrosis
factor-a, interleukin (IL)-1b, and IL-6, and significantly increased the anti-inflammatory
cytokine IL-10 levels. Results indicated that the oils effectively inhibited the secretion of
nitric oxide and prostaglandin E2 in lipopolysaccharide-stimulated macrophages. Western
blot analyses were performed to determine whether the inhibitory effects of the oils on
proinflammatory mediators (nitric oxide and prostaglandin E2) were related to the mod-
ulation of inducible nitric oxide synthase and cyclooxygenase-2 expression. These findings
suggest that T. roylei essential oils exert an anti-inflammatory effect by regulating the
expression of inflammatory cytokines.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inflammation is a local tissue defensive reaction in response
to infection and tissue injury, leading to local accumulation ofnce and Engineering, So
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.org/licenses/by-nc-nd/4.0/plasma and blood cells [1] and the release of inflammatory
mediators, which finalize the restoration of tissue structure
and function. However, if inflammation remains untreated,
the condition can be detrimental and may lead to an onset of
certain diseases, such as asthma, rheumatoid arthritis,uth China University of Technology, 381 Wushan Road, Tianhe
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inflammatory agents may be helpful in the treatment of in-
flammatory disorders [3]. Traditionally, the pharmacotherapy
of inflammatory conditions is based on the use of steroidal
anti-inflammatory drugs (SAIDs) or non-SAIDs (NSAIDs). The
use of SAIDs, such as glucocorticoids, as anti-inflammatory
agents are now controversial because of their multiple side
effects, including osteoporosis, myophagism, and metabolic
disturbance [4]. Prolonged use of NSAIDs, such as aspirin,
ibuprofen, and indomethacin, can cause serious gastrointes-
tinal toxicity [5]. Some NSAIDs have also been linked to
increased blood pressure, considerably increased risk of
congestive heart failure, and occurrence of thrombosis [6].
Hence, the discovery of novel and safer anti-inflammatory
drugs is constantly needed. Interest in traditional medicinal
plants, which are important sources of new chemical sub-
stances with potential therapeutic effects, has been growing
[7]. Essential oils (EOs) extracted from various herbs and spices
have been used in medicine, food, and cosmetics primarily
because of the continuous discovery of their multifunctional
properties. The anti-inflammatory effects of many EOs have
also been investigated [8,9].
Trachydium, which is classified from the tribe Smyrnieae of
the Apiales, is a genus of perennial herbs. This genus com-
prises approximately 10 species that are widespread from
Siberia to the Himalayan region [10]. Trachydium roylei is a
4e10 cm tall perennial herb with a light and camphor-like
odor and is usually acaulescent. This species is primarily
distributed in the alpine grasslands of Central Asia, and it
provides a long reputed medicinal value in traditional local
medicine for the treatment of hypertension, fever, inflam-
mation, and scabies.
However, the chemical composition and biological activ-
ities of T. roylei have not been described. Therefore, in the
current study, the EOs of T. roylei were investigated for their
chemical composition and anti-inflammatory activity. To our
knowledge, this study is the first to report on the anti-
inflammatory activity of T. roylei extract.2. Methods
2.1. Plant material and chemicals
The aerial parts of T. roylei were collected from the Pamirs,
Xinjiang Region, China, in June 2014. The plant specimens
were identified [10]. The plants were dried under shade at
room temperature. The voucher specimen (number
IBSC0462255) was deposited in the South China Botanical
Garden, Chinese Academy of Sciences.
Dimethyl sulfoxide, 3-(4,5-dimethylthiazol-2-y1)-2,5-
diphenyltetrazolium bromide (MTT), and phosphate-
buffered saline were purchased from SigmaeAldrich (St.
Louis, MO, USA). Dulbecco's modified Eagle's medium and
fetal bovine serum were obtained from Invitrogen-Gibco
(Grand Island, NY, USA). Enzyme-linked immunosorbent
assay (ELISA) kits for prostaglandin E2 (PGE2), tumor necrosis
factor (TNF)-a, interleukin (IL)-1b, and IL-6 were purchased
from R&D Systems Inc. (St. Louis, MO, USA), and ELISA kits
for IL-10 were purchased from BioLegend (San Diego, CA,USA). Antibodies against cyclooxygenase-2 (COX-2) and
inducible nitric oxide synthase (iNOS) were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA), and the
antibody against b-actin was purchased from Chemicon
(Temecula, CA, USA). Other chemicals and reagents were of
analytical grade.2.2. Isolation of EOs
Air-dried plant materials (300 g) of T. roylei were chopped and
subjected to hydrodistillation for 5 hours using a Clevenger-
type apparatus. The obtained oils were dried with sodium
sulfate for 24 hours, filtered, and stored at 4C in sealed brown
glass vials until analysis.2.3. Gas chromatography analysis
An Agilent HP-6890 gas chromatograph (Agilent Technologies,
Palo Alto, CA, USA), which comprised an HP-5 5% phenyl-
methylsiloxane capillary column (30 m  0.25 mm internal
diameter, 0.25 mm film thickness) and an flame ionization
detector detector, was used for gas chromatography (GC)e
flame ionization detector analysis. Helium gas at a constant
flow rate of 1 mL/min was used as the carrier gas. Injector and
mass transfer line temperatures were set at 250C and 280C,
respectively. The EO solution (1 mL) in hexanewas injected and
analyzed under the following column conditions: initial col-
umn temperature of 40C for 1 minute, increased to 250C at a
3C/min heating ramp, and subsequently maintained at 250C
for 20 minutes.2.4. GCeMS analysis
The EOs were quantitatively and qualitatively analyzed using
a GCemass spectrometry (MS) 6890-5975 system (Agilent
Technologies, Palo Alto, CA, USA) equipped with a HP-5 MS
fused silica capillary column (30 m  0.25 mm internal
diameter, 0.25 mm film thickness). For GCeMS detection, an
electron ionization system with 70 eV of ionization energy
was used. Helium gas was used as the carrier gas with a
constant flow rate of 1 mL/min. Injector and mass transfer
line temperatures were set at 250C and 280C, respectively.
One microliter of EO solution in hexane was injected and
analyzed under the following column conditions: initial col-
umn temperature at 40C for 1 minute, increased to 250C at
a 3C/min heating ramp, and maintained at 250C for 20 mi-
nutes. Kovats indices were calculated for all volatile compo-
nents using a homologous series of n-alkanes (C8eC25) in a
HP-5 MS column. The major oil components were identified
by coinjection with standards (whenever possible) and
confirmed with the Wiley version 7.0 (John Wiley & Sons
Inc.,Hoboken, NJ, USA) and National Institute of Standards
and Technology version 2.0 GC-MS library(the National
Institute of Standards and Technology (NIST) is an agency of
the U.S. Department of Commerce) using the Kovats indices.
The relative concentration of each EO compound was quan-
tified on the basis of the peak area integrated in the analysis
program.
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RAW 264.7 cells belonging to a murine macrophage cell line
were purchased from the China Center for Type Culture
Collection (Shanghai, China). These cells (2  105) were
cultured in a 96-well plate containing Dulbecco's modified
Eagle's medium (Sigma) and supplemented with 10% fetal
bovine serum in a CO2 incubator (5% CO2) at 37C.
2.6. Cell viability
Cells were preincubated for 24 hours in a CO2 incubator, pre-
treatedwith several EO concentrations (0 mg/mL, 1.25mg/mL,
2.5 mg/mL, 5.0 mg/mL, 10 mg/mL, 20 mg/mL, and 40 mg/mL)
for 1 hour, and costimulated with 100 ng/mL lipopolysaccha-
ride (LPS) for 24 hours at 37 C. Afterwards, the cells were
washed twice with phosphate-buffered saline and incubated
with 100 mL of 0.5-mg/mL MTT for 2 hours to determine the
cell viability. The medium was discarded, and 100 mL of
dimethyl sulfoxide was added. After 30-minutes incubation,
the absorbance at 570 nm was determined using a microplate
reader.
2.7. Measurement of nitric oxide, PGE2, TNF-a, IL-1b,
IL-6, and IL-10 levels
RAW 264.7 cells were placed in a 12-well plate at a density of
2  105 cells/well and incubated for 24 hours. The cultured
cells were treated with various EO concentrations (0 mg/mL,
2.5 mg/mL, 5.0 mg/mL, 10 mg/mL, and 20 mg/mL) for 1 hour
and stimulated with 100-ng/mL LPS for 24 hours. The cultured
media were collected after centrifugation at 2000g for 10 mi-
nutes and stored at 80C until analysis. The nitrite concen-
tration in the culturedmedia was measured as an indicator of
nitric oxide (NO) production based on the Griess reaction [11].
The levels of PGE2, IL-1b, IL-6, IL-10, and TNF-a in cultured
media were quantitated with ELISA (R&D Systems) in accor-
dance with the manufacturer's instructions.
2.8. Western blot analysis
RAW 264.7 cells placed in a 12-well plate were pretreated with
various EO concentrations (0 mg/mL, 2.5 mg/mL, 5.0 mg/mL,
10 mg/mL, and 20 mg/mL) for 1 hour and stimulated with LPS
for 6 hours. After the incubation period, the cells were scraped
from flasks and lysed in a lysis buffer [100 mL: 50mM Tris (pH
7.5), 150mM NaCl, 1mM EDTA, 0.1M (volume/volume) sodium
dodecyl sulfate, 1% (volume/volume) Triton X-100, 1mM
phenylmethane sulfonyl fluoride, 10 mg/mL aprotinin, 10 mg/
mL leupeptin, and 10 mg/mL pepstain]. Samples were boiled at
100C for 5minutes and centrifuged at 16,627g for 2minutes at
4C. Protein extracts were run on 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis gels and transferred onto
polyvinylidene difluoride membranes (Millipore, Boston, MA,
USA). The membranes were blocked with 5% nonfat dry milk
in Tris-buffered saline and Tween 20 buffer for 1 hour at room
temperature. Afterward, the membranes were incubated with
an appropriate dilution ratio of the relative primary antibody
overnight at 4C. Themembranes were further incubatedwith
the secondary antibody for 4 hours at room temperature anddetected using an enhanced chemiluminescence reagent. The
membranes were washed three times and the immunoreac-
tive proteins were detected with an enhanced chem-
iluminescence system (GE Healthcare, Little Chalfont,
Buckinghanshire, UK). The results of theWestern blot analysis
were quantified by measuring the relative intensity compared
to the control and represented in the relative intensities.
Mouse b-actin was simultaneously detected as an internal
control to monitor the intensity. Bands for iNOS, COX2, and b-
actin antibodies were recognized at ~135 kDA, ~72 kDA, and
~45 kDa, respectively.
2.9. Statistical analysis
Data were presented as means ± standard deviation. For sta-
tistical analysis, the data were analyzed by one-way analysis
of variance followed by Duncan post hoc pair-wise compari-
sons between groups. Significant difference between groups
was determined at p < 0.05.3. Results
3.1. EO yield and chemical composition
The steam distillation of 300 g of dried plant material yielded
5.6 mL (1.80%, volume/weight) of yellow oils with a distinct
smell. The oil samples were analyzed using GCeMS. Their
components were identified in terms of their retention index
values and mass spectra compared with those reported in
previous studies. The GCeMS analysis results of T. roylei EO
revealed 59 components, representing 98.87% of the oils
(Table 1). The components of the EOs were 30.38% mono-
terpene hydrocarbon fraction, 2.22% sesquiterpene hydro-
carbon fraction, 6.51% oxygenated monoterpene fraction,
14.69% oxygenated sesquiterpenoid fraction, 41.53% aromatic
compounds, and 3.54% other components. The main compo-
nents of the oils were myristicin (25.35%), b-phellandrene
(22.95%), elemicine (7.69%), isoelemicin (5.48%), and cedrol
(5.26%).
3.2. Cell viability
The effect of oils on RAW 264.7 cell viability was determined
using MTT assay. Figure 1 shows the cell viability at 1.25-mg/
mL, 2.5-mg/mL, 5-mg/mL, 10-mg/mL, 20-mg/mL, and 40-mg/
mL EOs in the presence of LPS (100 ng/mL). A low oil concen-
trationwith 100-ng/mL LPS incubation for 24 hours showed no
effects on cell viability. By contrast, 40-mg/mL EO significantly
decreased the cell viability to ~76.3% (p < 0.001).
3.3. Effects of EOs on LPS-induced inflammatory
cytokines
Proinflammatory cytokines, such as TNF-a, IL-1b, and IL-6,
and the anti-inflammatory cytokine IL-10 play important
roles in the inflammatory process. The treatment of RAW
264.7 cells with LPS alone resulted in an increased release of
pro- and anti-inflammatory cytokines (TNF-a, IL-1b, IL-6, and
IL-10) compared with that in nonactivated controls (Figure 2).
Table 1 e Chemical components of essential oils obtained by hydrodistillation of Trachydium roylei.
Peak no. RIa Components %RAb Identification
methods
Peak no. RIa Components %RAb Identification
methods
Monoterpene hydrocarbons 30.38 30 1598 Guaiol 0.21 MS, RI
1 936 a-Pinene 1.21 MS, RI 31 1605 Cedrol 5.26 MS, RI, Co
2 966 b-Thujene 0.26 MS, RI 32 1621 Fonenol 0.21 MS, RI
3 978 Pinene 0.15 MS, RI 33 1630 a-Acorenol 3.13 MS, RI
4 986 b-Myrcene 1.13 MS, RI 34 1639 Isospathulenol 0.22 MS, RI
5 1008 a-Phellandrene 0.48 MS, RI 35 1652 Bisabolol oxide 0.68 MS, RI
6 1024 b-Phellandrene 22.95 MS, RI, Co Aromatic compounds 41.53
7 1040 (E)-b-Ocimene 0.33 MS, RI 36 1196 Estragole 0.21 MS, RI
8 1045 (Z)-b-Ocimene 1.05 MS, RI 37 1323 Mesitaldehyde 0.29 MS, RI
9 1059 g-Terpinene 0.52 MS, RI 38 1410 Methyleugenol 2.01 MS, RI
10 1083 Terpinolene 2.08 MS, RI 39 1518 Myristicin 25.35 MS, RI, Co
11 1111 1,3,8-p-Menthatriene 0.22 MS, RI 40 1521 Calamenene 0.34 MS, RI
Oxygenated monoterpenes 2.22 41 1556 Elemicine 7.69 MS, RI, Co
12 1140 E-Pinocarveol 0.31 MS, RI 42 1657 Isoelemicin 5.48 MS, RI, Co
13 1160 Isoborneol 0.24 MS, RI 43 1682 Apiol 0.16 MS, RI
14 1178 Terpinene-4-ol 0.2 MS, RI Others 3.54
15 1187 Crypton 1.13 MS, RI 44 855 Isononane 0.16 MS, RI
16 1190 a-Terpineol 0.16 MS, RI 45 901 Isobutyl isobutyrate 0.22 MS, RI
17 1273 Phellandral 0.18 MS, RI 46 1006 Isovaleric acid, isobutyl ester 0.18 MS, RI
Sesquiterpene hydrocarbons 6.51 47 1012 3-Carene 0.22 MS, RI
18 1372 a-Copaene 0.33 MS, RI 48 1014 Isobutyric acid, isopentyl ester 0.24 MS, RI
19 1394 ()-b-Elemene 0.37 MS, RI 49 1016 Isobutyric acid, 2-methylbutyl ester 0.18 MS, RI
20 1417 Caryophyllene 1.38 MS, RI 50 1018 o-Cymene 0.24 MS, RI
21 1456 Humulene 1.19 MS, RI 51 1043 Benzeneacetaldehyde 0.34 MS, RI
22 1480 Germacrene D 0.54 MS, RI 52 1101 Isopentyl 2-methylbutanoate 0.15 MS, RI
23 1503 Bicyclogermacrene 2.51 MS, RI 53 1103 n-Amyl isovalerate 0.13 MS, RI
24 1516 a-Muurolene 0.19 MS, RI 54 1105 Isoamyl valerianate 0.27 MS, RI
Oxygenated sesquiterpenes 14.69 55 1134 Cosmene 0.22 MS, RI
25 1562 (trans)-Nerolidol 1.17 MS, RI 56 1230 Cumaldehyde 0.27 MS, RI
26 1566 Spathulenol 0.74 MS, RI 57 1242 trans-Chrysanthenyl acetate 0.23 MS, RI
27 1572 ()-Spathulenol 0.79 MS, RI 58 1282 L-bornyl acetate 0.24 MS, RI
28 1578 Caryophyllene oxide 2.09 MS, RI 59 1357 Citronellol acetate 0.25 MS, RI
29 1594 Isoaromadendrene epoxide 0.19 MS, RI Total identified (%) 98.87
Co ¼ coinjection with authentic compound; MS ¼ mass spectrum; RI ¼ retention index.
a Retention index relative to n-alkanes on HP-5 MS capillary column.
b Relative area (peak area relative to the total peak area).
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Figure 1 e Growth inhibitory effect of Trachydium roylei
essential oil in lipopolysaccharide (LPS)-stimulated RAW
264.7 cells. Values are expressed as mean ± standard
deviation (n ¼ 3). * p < 0.001 compared with the LPS-only
treatment group. Ctrl ¼ control.
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IL-6 (Figure 2C) in RAW 264.7 cells by LPS stimulation
remarkably decreased in a dose-dependent manner after the
cells were exposed to EOs (p < 0.05). By contrast, the anti-
inflammatory cytokine IL-10 level significantly increased in a
dose-dependent manner after the cells were exposed to the
EOs (p < 0.05; Figure 2D).
3.4. Effects of EOs on LPS-induced production of NO and
PGE2
The production of NO and PGE2 was examined in RAW
264.7 cells stimulated with LPS for 24 hours in the presence or*
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Figure 2 e (A) Effects of Trachydium roylei essential oil on lipopo
production of RAW 264.7 macrophages; (B) effects of T. roylei es
RAW 264.7 macrophages; (C) effects of T. roylei essential oil on LP
(D) effects of T. roylei essential oil on LPS-induced IL-10 product
mean ± standard deviation (n¼ 3). * Indicates p < 0.001 compare
only treatment group. *** p < 0.001 compared with the LPS-onlyabsence of EOs. The production of NO,whichwasmeasured as
nitrite, was increased by LPS treatment. By contrast, EOs
(2.5 mg/mL, 5 mg/mL, 10 mg/mL, and 20 mg/mL) significantly
reduced the NO levels in LPS-stimulated cells in a dose-
dependent manner (p < 0.05; Figure 3A). The increased PGE2
production by LPS in RAW 264.7 cells was also significantly
suppressed by the EOs (2.5 mg/mL, 5 mg/mL, 10 mg/mL, and
20 mg/mL; Figure 3B).
3.5. Effects of EOs on LPS-induced protein expression of
iNOS and COX-2
To investigate whether the inhibitory effects of EOs on the
production of NO and PGE2 were mediated by inhibition of
gene expression,we evaluated iNOS and COX-2 usingWestern
blot analysis. Macrophages were treated with EOs (2.5 mg/mL,
5 mg/mL, 10 mg/mL, and 20 mg/mL) to examine the protein
expression of inflammation-associated molecules triggered
by LPS (Figure 4). In these experiments, LPS-activated macro-
phages increased the protein expression levels of COX-2 and
iNOS compared with those in the untreated control group. By
contrast, EO treatment downregulated the expression of these
LPS-stimulated proteins in a concentration-dependent
manner (p < 0.05).4. Discussion
As natural volatile substances from plants, EOsmay represent
an alternative source of anti-inflammatory agents because
they are not usually extracted as chemically pure substances,0
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Figure 3 e (A) Effects of Trachydium roylei essential oil on lipopolysaccharide (LPS)-induced nitric oxide production of RAW
264.7 macrophages; and (B) effects of T. roylei essential oil on LPS-induced prostaglandin E2 (PGE2) production of RAW 264.7
macrophages. Values are expressed as mean ± SD (n¼ 3). * Indicates p < 0.001 compared with the control group. ** Indicates
p < 0.001 compared with the LPS-only treatment group. Ctrl ¼ control.
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compounds that are biodegradable into nontoxic products
and potentially suitable for use in integrated management
programs [12]. In the present study, the chemical composition
of T. roylei EO and its anti-inflammatory effects on LPS-
stimulated RAW 264.7 macrophage cells were investigated.
The results of phytochemical analysis demonstrated that T.
roylei EO is predominantly composed of aromatic compounds
and monoterpene hydrocarbons, and the major chemical
compounds detected were myristicin and b-phellandrene
(Table 1). To our knowledge, this study is the first to assess the
chemical composition and bioactivity of the genus
Trachydium.
Inflammation is a bodily response to harmful stimuli such
as injury and infection [13]. Various inflammatory models
allow evaluation of test compounds and provide further un-
derstanding about the inflammatory process. Macrophages
are essential for innate immunity and play an important role
in both host defense mechanism and inflammation [14].
Pathogenic bacteria and other infectious agents can stimu-
late macrophages directly, thereby initiating the release of
proinflammatory mediators, such as NO, PGE2, TNF-a, and IL-
1b, to sustain inflammation and the immunological response
[15,16]. However, overproduction of these mediators canFigure 4 e Inhibitory effect of T. roylei essential oil on protein ex
cells. The results presented are representative of three indepen
(n ¼ 3). ### indicates p < 0.001 compared with the control grou
compared with the LPS-only treatment group. TREO¼essentialharm tissues and organisms and has been associated with
the pathogenesis of various inflammatory-related diseases,
such as rheumatoid arthritis, diabetes, inflammatory bowel
disease, atherosclerosis, and cancer [17]. In many studies,
anti-inflammatory compounds have been investigated for
their potential inhibitory effects in vitro using LPS-stimulated
RAW 264.7 macrophages. LPS, a component of the outer
membrane of gram-negative bacteria, can activate murine
macrophages [18] and induce an oversecretion of various
inflammatory and toxicity-mediating molecules, such as
TNF-a, IL-6, eicosanoids, and NO [19]. Therefore, this cell
system is an excellent model for drug screening and subse-
quent evaluation of potential inhibitors against iNOS and NO
production [20].
To further understand the molecular mechanisms of the
anti-inflammatory activity of T. roylei EO, we investigated
the effects of such EOs on the secretion of NO, PGE2, TNF-a,
IL-1b, IL-6, and IL-10, as well as on the expression of iNOS
and COX-2 in LPS-induced RAW 264.7 macrophages.
Furthermore, these oils were found to be safe for mamma-
lian macrophages at concentrations ranging from 1.25 mg/
mL to 20 mg/mL.
To analyze the anti-inflammatory mechanism mediated
by T. roylei EO, we investigated the effects of these EOs on LPS-0
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cytokines, such as IL-1b and IL-6, as well as TNF-a and the
anti-inflammatory cytokine IL-10, which are regarded as
crucial anti-inflammatory targets [21]. Proinflammatory cy-
tokines, such as TNF-a, IL-1b, and IL-6, are produced pri-
marily by activated monocytes or macrophages. Moreover,
TNF-a and IL-1b can induce and/or enhance PGE2 production
in macrophages [22e24]. IL-6 is characterized as an inflam-
matory factor because it synergistically augments the in-
flammatory actions of IL-1 in human synovial cells [25]. The
treatment of RAW 264.7 cells with LPS alone resulted in a
significant increase in proinflammatory cytokine production
compared with that in the control group (p < 0.001). By
contrast, T. roylei EO significantly reduced these cytokine
levels (p < 0.001; Figures 2AeC). IL-10 is generally considered
as an anti-inflammatory and immunosuppressive cytokine,
and its inhibitory effect on the production of inflammatory
cytokines, including TNF-a, IL-1b, and IL-6, has been
demonstrated in numerous studies [26e28]. In the current
study, EOs from T. roylei significantly increased the levels of
anti-inflammatory cytokine IL-10 (Figure 2D). Therefore, the
regulation of cytokines observed in this studymay reflect one
of the mechanisms underlying the anti-inflammatory effect
of T. roylei EO.
Inducible COX-2 is responsible for the high prostaglandin
levels observed in several inflammatory pathologies. Simi-
larly, iNOS produces large amounts of NO and is thought to
play a central role in inflammatory diseases [29,30].
Numerous studies have reported that NO and PGE2 partici-
pate in inflammatory and nociceptive events [31]. Addition-
ally, our results indicated that T. roylei EO effectively
inhibited the secretion of NO and PGE2 in LPS-stimulated
macrophages (Figure 3). Western blot analyses determined
whether the inhibitory effects of the EOs on proinflammatory
mediators (NO and PGE2) were related to the modulation of
iNOS and COX-2 expression levels (Figure 4). In addition,
according to the previous literature, the anti-inflammatory
mechanisms of some components found in the oil, such as
myristicin, have been studied. Myristicin has anti-
inflammatory properties related with its inhibition of NO,
cytokines, chemokines, and growth factors in double
stranded RNA-stimulated macrophages via the calcium
pathway [32].5. Conclusion
In conclusion, our study is a pioneer report about the
chemical composition and bioactivities of T. roylei EOs. This
study showed that the anti-inflammatory activity of T. roylei
EOs depends on its ability to regulate the expression of NO,
PGE2, TNF-a, IL-1b, IL-6, and IL-10. Overall, this study sug-
gests T. roylei EO as an effective agent to treat inflammatory
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